169 Participants Needed

Behavioral Probe for Grief and Suicide Risk

(RISE Trial)

SS
EC
Overseen ByEmilee Croswell, BA
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pittsburgh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment WELL Behavioral Probe for grief and suicide risk?

Research shows that behavior therapy, which is similar to the WELL Behavioral Probe, is effective in reducing suicidal attempts and ideation. Additionally, Problem Solving Therapy, a type of behavioral treatment, has been shown to reduce suicide risk in older adults by improving coping skills.12345

Is the WELL Behavioral Probe generally safe for humans?

There is limited information on the safety of behavioral interventions like the WELL Behavioral Probe, as adverse events are often underreported or not consistently defined in studies. However, in a study of psychosocial treatments, no serious adverse events were found to be related to the study, suggesting that such interventions are generally considered safe.678910

How does this treatment differ from other treatments for grief and suicide risk?

This treatment is unique because it focuses on using cognitive-behavioral therapy (a type of talk therapy that helps change negative thought patterns) specifically for individuals at high risk of complicated grief and suicide ideation, particularly those who have lost someone to suicide. It aims to reduce maladaptive grief reactions and potentially lower the risk of suicide by addressing the specific needs of those with a history of mental disorders and suicidal behavior.1112131415

What is the purpose of this trial?

The purpose of the RISE study is to examine how the 24-hour rhythm of sleep and social activity relate to mood and suicidal ideation among older adults that recently lost a spouse or life partner.

Research Team

SS

Sarah Stahl, PhD

Principal Investigator

University of Pittsburgh

Eligibility Criteria

This trial is for people aged 65 or older who have lost a spouse or life partner within the last year. They must have a history of suicide attempts, major depression without psychosis, or be currently experiencing significant depressive symptoms. Individuals with schizophrenia, bipolar disorder, current psychosis, cognitive impairment, or those living in nursing homes are not eligible.

Inclusion Criteria

No major cognitive impairment: TICS score of ≥ 27
I lost my spouse or partner less than a year ago.
I am 65 years old or older.
See 4 more

Exclusion Criteria

I have been diagnosed with schizophrenia, schizoaffective disorder, bipolar disorder, or have had psychosis.
Current shift worker
Resides in a nursing home
See 5 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Behavioral Probe

Participants complete a 3-month behavioral probe designed to promote self-care behaviors using technology and motivational health coaching, focusing on regular routines of sleep, meals, and social activities.

12 weeks
Monthly assessments

Follow-up

Participants are monitored for changes in perceived loneliness and suicidal ideation over 12 months using the UCLA Loneliness Scale and Beck Scale for Suicidal Ideation.

12 months
Assessments at month 1, 2, 3, 6, 9, and 12

Treatment Details

Interventions

  • WELL Behavioral Probe
Trial Overview The RISE study is testing how sleep and social activity patterns over a full day affect mood and thoughts of suicide in older adults grieving the recent loss of their spouse. The WELL Behavioral Probe will be used to monitor these rhythms.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: WELL Behavioral ProbeExperimental Treatment1 Intervention
Digital monitoring of sleep, meals, and social activity, for 3 months.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Findings from Research

A clinical trial comparing behavior therapy to insight-oriented therapy for repeated suicide attempters showed that behavior therapy was more effective in reducing depression, anxiety, and suicidal ideation over a nine-month follow-up period.
The success of the behavior therapy package was attributed to its structured approach and assertive follow-up, which likely enhanced patient outcomes during the ten-day inpatient treatment.
Behavior therapy vs insight-oriented therapy for repeated suicide attempters.Liberman, RP., Eckman, T.[2019]
This clinical trial will evaluate the effectiveness of an updated version of Problem Solving Therapy (emotion-centered PST) combined with enhanced usual care (EUC) in reducing suicidal ideation among 150 older Veterans with active suicidal thoughts, compared to EUC alone.
The study aims to assess changes in suicidal ideation and reasons for living over multiple time points, providing insights into how effective EC-PST is in improving coping skills and potentially informing future clinical guidelines for suicide prevention in this high-risk group.
Beyond maintaining safety: Examining the benefit of emotion-centered problem solving therapy added to safety planning for reducing late life suicide risk.Beaudreau, SA., Lutz, J., Wetherell, JL., et al.[2023]
A pilot study involving 17 older adults at risk for suicide showed that a 16-session Interpersonal Psychotherapy (IPT) intervention significantly reduced suicide ideation and depressive symptoms.
Participants also reported improvements in psychological well-being, social adjustment, and perceived social support, indicating that this adapted IPT could be beneficial for older adults in mental health care.
Adapting interpersonal psychotherapy for older adults at risk for suicide.Heisel, MJ., Talbot, NL., King, DA., et al.[2022]

References

Behavior therapy vs insight-oriented therapy for repeated suicide attempters. [2019]
Beyond maintaining safety: Examining the benefit of emotion-centered problem solving therapy added to safety planning for reducing late life suicide risk. [2023]
Adapting interpersonal psychotherapy for older adults at risk for suicide. [2022]
Successful Treatment of Suicidal Risk. [2022]
Behavioral treatments of suicidal behaviors. Definitional obfuscation and treatment outcomes. [2022]
The need for expanded monitoring of adverse events in behavioral health clinical trials. [2012]
Variability in the definition and reporting of adverse events in suicide prevention trials: an examination of the issues and a proposed solution. [2022]
Defining and assessing adverse events and harmful effects in psychotherapy study protocols: A systematic review. [2023]
Serious adverse events in randomized psychosocial treatment studies: safety or arbitrary edicts? [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
Development of a Trigger Tool to Identify Adverse Events and Harm in a Neuropsychiatry Setting. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
The broken heart: suicidal ideation in bereavement. [2015]
The effectiveness of family-based cognitive-behavior grief therapy to prevent complicated grief in relatives of suicide victims: the mediating role of suicide ideation. [2018]
Suicidal ideation in elderly bereaved: the role of complicated grief. [2007]
14.United Statespubmed.ncbi.nlm.nih.gov
Indirect self-destructive behavior and overt suicidality in patients with complicated grief. [2019]
15.United Statespubmed.ncbi.nlm.nih.gov
Understanding grief reactions, thwarted belongingness, and suicide ideation in bereaved adolescents: Toward a unifying theory. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security